Barclays’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
Barclays's RXST Position: Q1 2026 in Review
Barclays reduced its RxSight (RXST) stake by 96% in Q1 2026, selling an estimated $3.76M and leaving 20,765 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #3925.
Barclays first reported a position in RXST in Q1 2022 and has held it in 17 quarters since. The position peaked at $4.93M in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- Barclays held 20,765 shares of RxSight worth $128K as of Q1 2026.
- Barclays sold 452,802 RxSight shares in Q1 2026, an estimated $3.76M.
- RxSight made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3925 holding.
- Barclays first reported a position in RxSight in Q1 2022 and has held it in 17 quarters since.
- Barclays's RxSight position peaked at $4.93M in Q4 2025.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.